Intravascular lithotripsy in saphenous vein grafts and graft stent failure: A case series

Anja Øksnes1, Margaret McEntegart2

  • 1Department of Cardiology, Haukeland University Hospital, Bergen, Norway.

Insights

Saphenous vein graft (SVG) failure often requires revascularization. Intravascular lithotripsy (IVL) was used for calcium modification in patients undergoing percutaneous coronary intervention (PCI) for SVG disease, showing promising results.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Medical Devices

Background:

  • Saphenous vein grafts (SVGs) exhibit inferior long-term patency compared to arterial grafts, frequently necessitating revascularization via percutaneous coronary intervention (PCI).
  • Percutaneous coronary intervention (PCI) in SVGs is challenging due to graft degeneration, particularly calcification in older grafts, and is associated with high stent failure rates.
  • Intravascular lithotripsy (IVL) has proven effective for treating calcified coronary artery disease, but its application in SVG interventions remains largely unexplored.

Observation:

  • This study presents the first case series detailing the use of IVL in five patients undergoing PCI for de novo SVG disease or SVG stent failure.
  • The patients presented with varying degrees of SVG degeneration, with calcification being a significant factor in graft failure or stent restenosis.

Findings:

  • Intravascular lithotripsy (IVL) was utilized as a calcium modification strategy prior to stenting in all five patients undergoing PCI for SVG disease.
  • The procedure was technically successful in all cases, facilitating stent delivery and expansion in heavily calcified SVG lesions.
  • No immediate procedural complications related to IVL use were reported.

Implications:

  • These initial findings suggest that IVL may be a safe and effective option for treating calcified lesions within SVGs during PCI.
  • Further research and larger studies are warranted to confirm the long-term efficacy and safety of IVL in SVG interventions.
  • IVL could potentially improve PCI outcomes in patients with SVG disease, offering an alternative to suboptimal treatment strategies.